The Josamycin Market continues to expand as infectious disease specialists, pulmonologists, and pediatricians increasingly recognize the therapeutic value of this 16-membered macrolide antibiotic for managing respiratory and atypical infections. With josamycin offering distinct pharmacokinetic advantages including excellent tissue penetration, favorable intracellular accumulation, and a safety...